Comparative Study On Role Of Jalaukavcharana And Yashtyadi Lepa In Hordeolum

Not yet recruiting

• Conditions: Hordeolum (externum) (internum) ofeyelid,

• Registration Number: CTRI/2019/07/020000
• Lead Sponsor: Rishikul Campus

Brief Summary

*Ayurveda*, the most rational and scientific among the ancient systems of medicine, has immense potential to tackle many medical problems*.* *Sushruta Samhita has* described 76 *Netrarogas*, out of which 21 are *Vartmagata Vikaras.**Anjananamika* is one of the *Vartmagata, Raktpradhan* and *Shastrakritya (bhedan) sadhya vyadhi.*The clinical features of *Anjanamika* resemble with an eye disease named as Hordeolum. It is an acute infection (usually Staphylococcal) involving either the glands of Zeis (External Hordeolum) or the Meibomian glands(Internal Hordeolum).*Anjananamika* is a raktaj *vyadhi* and for its intervention *jalaukavcharana, vidalak* and *seka* is selected as all three help in curing *rakta*j or *rakta-pitta* vitiated disorders. In this study, effort is made in the form of use of localised treatment with *Jaluakavcharana* and *Yashtyadi lepa followed by* *Seka*  and to find out a comparatively better alternate for Hordeolum among the both. The study will be intervened under 2 groups – group A ( *Jalaukavcharana* with *Yashtyadi Seka* and group B (*Vidalaka* with *Yashtyadi lepa* followed by *Yashtyadi Seka*) and duration of the trial will be of 5 days. The observation of patients will be carried out on day 1, on 3rd day and after completion of trial and after completion follow up will be done for 1 month

Detailed Description

Not available

Study Timeline

• Study Start: 2019-07-14
• Last Update Posted: 2019-11-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

patients having signs and symptoms of Anjananamika and External and Internal Hordeolum.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess the effect of therapy, objectively all signs and symptoms were given scoring depending upon their severity:	assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial
1-Cured:91-100% relief in signs and symptoms	assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial
4-Mild improvement:26-50% relief in signs and symptoms	assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial
2-Markedly improvement:76-90% relief in signs and symptoms	assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial
3-Moderately improvement:51-75% relief in signs and symptoms	assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial
5-Unchanged/no improvement:less than or equal to 25% relief in signs and symptoms	assessment will be done on 1st day ,3rd day and 5th day after trial. overall assessment after 5 days of trial

Secondary Outcome Measures

Name	Time	Method
exacerbation in signs and symptoms	1 month

Trial Locations

Locations (1)

Rishikul Campus UAU Haridwar; 🇮🇳 Hardwar, UTTARANCHAL, India

Rishikul Campus UAU Haridwar

🇮🇳Hardwar, UTTARANCHAL, India

Ranjana Negi

Principal investigator

7060187856

rnranjanasmart181@gmail.com